Research programme: kinase-targeted drug candidates - Array BioPharma/Ono Pharmaceutical
Latest Information Update: 25 May 2010
At a glance
- Originator Array BioPharma; Ono Pharmaceutical
- Class Small molecules
- Mechanism of Action Phosphotransferase modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 09 Nov 2005 Preclinical trials in Undefined in USA (unspecified route)
- 09 Nov 2005 Preclinical trials in Undefined in Japan (unspecified route)